This information was published on 2026-03-11T23:00:38 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2633740 |
| (220) |
09 Mar 2026
|
| (300) |
US, 10 Oct 2025, 99436273
|
| (511) (510) |
Class 42
Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals that treat systemic mastocytosis |
| (540) | OPTIMISM |
| (550) | Word |
| (730) |
Telios Pharma Inc.
|
| (750) |
Ashurst Australia
|
Find out more about publications on the About page.